$148.63–$172.32
Choose 64617 for percutaneous laryngeal muscle chemodenervation, such as treatment of spasmodic dysphonia. Choose 64616 when the treated muscles are in the neck.
On this page
CMS RVU26D · Effective 2026-10-01
64617 Laryngeal chemodenervation Medicare reimbursement rates in Florida
Reports percutaneous chemodenervation of a laryngeal muscle, commonly for spasmodic dysphonia, with EMG guidance included when performed. Compare 64617 office and facility rates across CMS payment localities in Florida.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 64617 in Florida?
Florida has 3 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 3 payment areas shown below, using the same CMS release.
Office / nonfacility
$159.46–$175.90
3 of 3 localities have a supported rate.
Facility setting
$95.28–$106.01
3 of 3 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Where 64617 pays more and less in Florida
3 payment localities
$159.46 to $175.90
Chemodenervation
About 64617: Percutaneous laryngeal chemodenervation
Reports percutaneous chemodenervation of a laryngeal muscle, commonly for spasmodic dysphonia, with EMG guidance included when performed.
This service delivers a chemodenervating agent through the skin into a targeted laryngeal muscle. Otolaryngologists and laryngologists commonly use it for adductor laryngeal dystonia, also called spasmodic dysphonia; a typical target is the thyroarytenoid muscle. Treatment may be performed in an office or facility. EMG guidance used to localize the muscle is included in the procedure when performed.
Report the code for unilateral treatment and document the indication, targeted muscle, injection, and laterality. For bilateral treatment, modifier 50 applies; CMS pays the bilateral procedure at 150%. Related postoperative visits during the 10-day global period are included. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and the others at 50%. Medicare does not pay an assistant at surgery for this service; co-surgeons and team surgery are not permitted.
CMS billing rules for 64617
- Global period
- Minor procedure with a 10-day global period: related postoperative visits for 10 days are included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- Bilateral procedure with modifier 50 is paid at 150%.
- Assistant at surgery
- Statutory restriction: assistant at surgery is not paid.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU1.85 · 39%
- Practice expense (office) RVU2.65 · 56%
- Malpractice RVU0.26 · 5%
10.4K
Medicare services in 2024 · #1450 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
64617 compared with similar codes
Office rates for Florida, from the same CMS release.
$345.70–$383.15
31570 describes therapeutic injection into vocal cord(s) by direct laryngoscopy. 64617 describes percutaneous laryngeal chemodenervation, with EMG guidance included when performed.
No office rate
31571 is therapeutic vocal-cord injection by direct laryngoscopy with an operating microscope or telescope. 64617 is percutaneous chemodenervation of laryngeal muscle.
Compare 64617 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
3 of 3 payment localities
Fort Lauderdale →
Office / nonfacility
$167.16
Facility
$99.15
Miami →
Office / nonfacility
$175.90
Facility
$106.01
Rest Of Florida →
Office / nonfacility
$159.46
Facility
$95.28
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
64617 billing questions
When should 64617 be used instead of 64616?
Use 64617 for percutaneous chemodenervation of laryngeal muscle or muscles. Code 64616 addresses chemodenervation of neck muscles, not the laryngeal target.
Can both sides be treated with 64617?
Yes. Report bilateral treatment with modifier 50; CMS pays it at 150%.
Can EMG guidance be billed separately?
EMG guidance is included when performed as part of 64617. Document the guidance and the muscle targeted.
Is the injected drug included in 64617?
The procedure code describes the chemodenervation service, not the drug supply. Report the applicable drug code separately when the drug is supplied and separately reportable.
Are postoperative visits separately reported during the global period?
Related postoperative visits during the 10-day global period are included in 64617.
How does the multiple-procedure rule affect payment?
For multiple procedures in the same session, CMS pays the highest-valued procedure in full and the others at 50%.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
7,16964612,,Destroy nerve face muscle,A,,1.37,2.58,,1.58,,0.29,4.24,3.24,0,010,0.10,0.80,0.10,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17064615,,Chemodenerv musc migraine,A,,1.80,2.28,,0.85,,0.62,4.70,3.27,0,010,0.10,0.80,0.10,2,2,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17164616,,Chemodenerv musc neck dyston,A,,1.49,2.31,,0.99,,0.50,4.30,2.98,0,010,0.10,0.80,0.10,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17264617,,Chemodener muscle larynx emg,A,,1.85,2.65,,0.64,,0.26,4.76,2.75,0,010,0.10,0.80,0.10,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17364620,,Injection treatment of nerve,A,,2.82,3.58,,1.83,,0.36,6.76,5.01,0,010,0.10,0.80,0.10,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17464624,,Dstrj nulyt agt gnclr nrv,A,,2.44,9.65,,1.33,,0.22,12.31,3.99,0,010,0.10,0.80,0.10,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
7,17564625,,Rf abltj nrv nrvtg si jt,A,,3.31,11.20,,1.65,,0.33,14.84,5.29,0,010,0.10,0.80,0.10,2,1,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00